VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 335 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $237,000 | 0.0% | 14,949 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $237,000 | -21.5% | 14,949 | +2.5% | 0.00% | -33.3% |
| Q4 2017 | $302,000 | +64.1% | 14,583 | +13.7% | 0.00% | +50.0% |
| Q3 2017 | $184,000 | -46.8% | 12,824 | -35.9% | 0.00% | -50.0% |
| Q2 2017 | $346,000 | +21.4% | 20,008 | -22.8% | 0.00% | 0.0% |
| Q1 2017 | $285,000 | -23.0% | 25,908 | +3.4% | 0.00% | -20.0% |
| Q4 2016 | $370,000 | -24.2% | 25,055 | +26.4% | 0.01% | -28.6% |
| Q3 2016 | $488,000 | +19.3% | 19,825 | -2.0% | 0.01% | 0.0% |
| Q2 2016 | $409,000 | +6.0% | 20,226 | +41.1% | 0.01% | 0.0% |
| Q1 2016 | $386,000 | -66.4% | 14,336 | +26.1% | 0.01% | -66.7% |
| Q4 2015 | $1,149,000 | -47.1% | 11,367 | -6.6% | 0.02% | -53.3% |
| Q3 2015 | $2,172,000 | -4.1% | 12,174 | +19.7% | 0.04% | +7.1% |
| Q2 2015 | $2,266,000 | +23.4% | 10,170 | +9.9% | 0.04% | +20.0% |
| Q1 2015 | $1,837,000 | +71.4% | 9,256 | +27.1% | 0.04% | +45.8% |
| Q4 2014 | $1,072,000 | +71.2% | 7,284 | +52.5% | 0.02% | +41.2% |
| Q3 2014 | $626,000 | -7.0% | 4,775 | -10.5% | 0.02% | -5.6% |
| Q2 2014 | $673,000 | -70.2% | 5,334 | -68.9% | 0.02% | -72.7% |
| Q1 2014 | $2,259,000 | -20.0% | 17,130 | -29.0% | 0.07% | -24.1% |
| Q4 2013 | $2,825,000 | +13.5% | 24,123 | +1.2% | 0.09% | +3.6% |
| Q3 2013 | $2,490,000 | +32.5% | 23,847 | +9.8% | 0.08% | +25.4% |
| Q2 2013 | $1,879,000 | – | 21,715 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |